CNR Institutional Research Information System

CERCHIA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.578
NA - Nord America 836
EU - Europa 502
SA - Sud America 432
AF - Africa 40
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.393
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 791
SG - Singapore 675
BR - Brasile 343
CN - Cina 319
VN - Vietnam 193
HK - Hong Kong 187
IT - Italia 161
FR - Francia 102
NL - Olanda 93
KR - Corea 45
IN - India 33
AR - Argentina 31
FI - Finlandia 29
JP - Giappone 29
GB - Regno Unito 26
DE - Germania 25
EC - Ecuador 20
MX - Messico 17
BD - Bangladesh 16
CA - Canada 15
CO - Colombia 13
ZA - Sudafrica 13
IQ - Iraq 11
RU - Federazione Russa 11
UA - Ucraina 11
UZ - Uzbekistan 11
CL - Cile 8
ID - Indonesia 8
PK - Pakistan 8
PL - Polonia 8
PE - Perù 7
AZ - Azerbaigian 6
IL - Israele 6
PY - Paraguay 6
EG - Egitto 5
MA - Marocco 5
SN - Senegal 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
AU - Australia 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ES - Italia 3
HU - Ungheria 3
IE - Irlanda 3
JO - Giordania 3
KG - Kirghizistan 3
SE - Svezia 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 3.393
Salva come PNG Salva come JPEG
Città #
Singapore 413
Santa Clara 231
Hong Kong 181
San Jose 105
Beijing 100
Los Angeles 88
Hefei 80
Lauterbourg 80
Ho Chi Minh City 70
Ashburn 50
Seoul 45
Naples 42
Hanoi 36
São Paulo 34
Dallas 24
Giugliano in Campania 23
Marigliano 19
Tokyo 19
Buffalo 14
New York 14
Belo Horizonte 12
Rome 11
Tashkent 11
Falkenstein 10
Helsinki 10
Brasília 9
Council Bluffs 9
Lappeenranta 9
Orem 9
Rio de Janeiro 9
Turku 9
Montreal 8
Quito 8
Shanghai 8
Afragola 7
Frankfurt am Main 7
Sorocaba 7
Curitiba 6
Guayaquil 6
Haiphong 6
Johannesburg 6
Lima 6
Manchester 6
Warsaw 6
Baku 5
Bengaluru 5
Da Nang 5
Dakar 5
Dhaka 5
Hải Dương 5
Quảng Ngãi 5
Seattle 5
Thái Nguyên 5
Vũng Tàu 5
Amsterdam 4
Atlanta 4
Bogotá 4
Casandrino 4
Chennai 4
Minamishinagawa 4
Osaka 4
Paris 4
Santiago 4
Thái Bình 4
Amman 3
Asunción 3
Baghdad 3
Bari 3
Bishkek 3
Biên Hòa 3
Boston 3
Buenos Aires 3
Caruaru 3
Ciudad del Este 3
Denver 3
Dubai 3
Dublin 3
Düsseldorf 3
Jakarta 3
Jaú 3
Kyiv 3
Lahore 3
London 3
Louisville 3
Marseille 3
Medellín 3
Milan 3
Nanjing 3
New Delhi 3
Nuremberg 3
Phủ Lý 3
Piracicaba 3
Salvador 3
Stockholm 3
Sumaré 3
São Bernardo do Campo 3
São Gonçalo 3
Vitória 3
Aracaju 2
Avellino 2
Totale 2.059
Salva come PNG Salva come JPEG
Nome #
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion 118
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 108
Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-?B 80
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 76
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 75
Optimization of Short RNA Aptamers for TNBC Cell Targeting 72
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy 70
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 66
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 64
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles 63
Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition 61
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer 61
Mechanism of Action of Lactic Acid on Histones in Cancer 60
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR beta Aptamer 59
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells 59
Profiling cancer cells by cell-selex: Use of aptamers for discovery of actionable biomarkers and therapeutic applications thereof 57
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression 56
Synthesis and functionalization of casein nanoparticles with aptamers for triple-negative breast cancer targeting 56
Subtype Transdifferenziation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression 55
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities 55
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 55
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype 52
The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement 52
Aptamer-Based Strategies to Boost Immunotherapy in TNBC 52
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene 50
PATZ1 is a new prognostic marker of diffuse large B cell lymphomas 50
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier 49
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation 49
Aptamers and antibodies: rivals or allies in cancer targeted therapy? 49
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas 47
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion 47
Affinity immobilization of aptamers on graphene oxide for biosensor applications 47
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 47
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. 46
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 46
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications 43
Engineering Aptamers for Biomedical Applications: Part II 43
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells 42
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 42
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 40
Novel human bispecific aptamer-antibody conjugates for efficient cancer cell killing 39
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 39
The isolectin IB4 binds RET receptor tyrosine kinase in microglia. 37
Ipilimumab and its derived EGFR aptamer-based conjugate induce efficient NK cell activation against cancer cells 37
inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRbeta aptamer 37
Highlighting the potential of aptamer-based strategy to treat EGFRvIII-positive glioblastoma. Cancer Cell Microenviron. 37
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death 37
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis 33
The chromosomal protein Sso7d of the crenarchaeon Sulfolobus solfataricus rescues aggregated proteins in an ATP hydrolysis-dependent manner 33
Proneural-mesenchymal transition: Phenotypic plasticity to acquire multitherapy resistance in glioblastoma 32
Distribution and bioactivity of the Ret-specific D4 aptamer in three-dimensional collagen gel cultures. 32
Nucleic acid aptamers for in vivo molecular imaging 31
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-6 31
Noncoding RNAs in Cancer Medicine. 30
Aptamers: Promising Tools for Cancer Diagnosis and Therapy 30
cleic acids in human glioma treatment: innovative approaches and recent results 30
Cell-specific aptamers for targeted therapies. 30
Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7 29
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas 29
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth 28
Aptamers are an innovative and promising tool for phytoplankton taxonomy and biodiversity research 28
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFR? Aptamer. 28
Coupling aptamers to short interfering RNAs as therapeutics 27
Shp2 in PC12 cells: NGF versus EGF 27
A red emitting carbon dot and aptamer-functionalized alginate system for targeted triple-negative breast cancer imaging 27
Differential SELEX in human glioma cell lines. 27
New insight into clinical development of nucleic acid aptamers. 27
A cross-talk between TrkB and Ret tyrosine kinases receptors mediates neuroblastoma cells differentiation. 25
PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas 25
Direct interactions among the tyrosine kinase receptor Ret, the GDNF and the GFR±1 molecules. 25
Recent advance in biosensors for microRNAs detection in cancer 25
Targeting Axl With an High-affinity Inhibitory Aptamer 24
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay 24
Targeting cancer cells with nucleic acid aptamers 24
An Autocrine Loop Involving Ret and Glial Cell-Derived Neurotrophic Factor Mediates Retinoic Acid-Induced Neuroblastoma Cell Differentiation 23
Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase 23
Aptamer-Based Technologies as New Tools for Proteomics in Diagnosis and Therapy Frontiers in Drug Design & Discovery 22
Urine-Stable Aptamer-Conjugated Gold Nanorods for the Early Detection of High-Grade Bladder Cancer Residual Disease 21
Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy 21
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRB aptamer 21
A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling 19
The Tumor Suppressive Role of PATZ1 in Thyroid Cancer: A Matter of Epithelial-Mesenchymal Transition 19
An archaeal chaperonin-based reactor for renaturation of denatured proteins. 18
An intracellular protease of the crenarchaeon Sulfolobus solfataricus, which has sequence similarity to eukaryotic peptidases of the CD clan 17
The chromosomal protein Sso7d of the crenarchaeon Sulfolobus solfataricus rescues aggregated proteins in an ATP hydrolysis-dependent manner. 16
Totale 3.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.869
article - articoli 10.400
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 314
Totale 21.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202459 0 0 0 0 0 0 0 0 5 0 19 35
2024/20251.322 31 10 98 33 218 57 46 95 85 134 253 262
2025/20262.182 80 262 207 316 361 167 349 105 143 122 70 0
Totale 3.563